SCHEMBL257703

SCHEMBL257703

COCc1nn2c(-c3cccc(C(F)(F)F)c3)cc(N3CCC[C@H]3CO)nc2c1-c1ccc(OC)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SPHK2 Q9NRA0 1/20 0.42
▸ SPHK1 Q9NYA1 1/20 0.42
▸ MEN1 O00255 1/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ PLAT P00750 1/20 0.40
▸ ITGB2 P05107 1/20 0.39
▸ ICAM1 P05362 1/20 0.39
▸ ITGAL P20701 1/20 0.39
▸ TRPV1 Q8NER1 2/20 0.37
▸ RPS6KB1 P23443 3/20 0.36
▸ CDK1 P06493 1/20 0.36
▸ MAPT P10636 2/20 0.36
▸ SCN9A Q15858 3/20 0.36
▸ FPR2 P25090 1/20 0.36
▸ LMNA P02545 1/20 0.36
▸ POLB P06746 1/20 0.36
▸ XBP1 P17861 1/20 0.36
▸ HTT P42858 1/20 0.36
▸ BLM P54132 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15020696 1.00 SPHK2 (0.42) SPHK2SPHK1MEN1ALDH1A1KMT2A
SCHEMBL15020534 0.94 SPHK2 (0.41) SPHK2SPHK1MEN1ALDH1A1KMT2A
SCHEMBL15042226 0.93 MEN1 (0.43) SPHK2SPHK1MEN1ALDH1A1KMT2A
SCHEMBL15020575 0.91 PLAT (0.42) SPHK2MEN1ALDH1A1KMT2APLAT
SCHEMBL257291 0.90 MAPT (0.47) SPHK2SPHK1MEN1ALDH1A1KMT2A
SCHEMBL15020944 0.90 SPHK2 (0.44) SPHK2SPHK1MEN1ALDH1A1KMT2A
SCHEMBL15020747 0.90 MAPT (0.47) SPHK2SPHK1MEN1ALDH1A1KMT2A
SCHEMBL27908976 0.89 PLAT (0.41) SPHK2MEN1ALDH1A1KMT2APLAT
SCHEMBL15021000 0.89 PLAT (0.41) SPHK2SPHK1PLATTRPV1CDK1
SCHEMBL15020996 0.89 PLAT (0.41) SPHK2SPHK1PLATTRPV1CDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8975264-B2 Compound acting as a cannabinoid receptor-1 inhibitor AMOREPACIFIC CORPORATION (KR) 2015-03-10 — — US disclosed
US-8975264-B2 Compound acting as a cannabinoid receptor-1 inhibitor AMOREPACIFIC CORPORATION (KR) 2015-03-10 — — US disclosed
US-8975264-B2 Compound acting as a cannabinoid receptor-1 inhibitor AMOREPACIFIC CORPORATION (KR) 2015-03-10 — — US disclosed
EP-2617723-A2 NOVEL COMPOUND ACTING AS A CANNABINOID RECEPTOR-1 INHIBITOR Amorepacific Corporation (KR) 2013-07-24 — — EP disclosed
US-20130158025-A1 NOVEL COMPOUND ACTING AS A CANNABINOID RECEPTOR-1 INHIBITOR AMOREPACIFIC CORPORATION (KR) 2013-06-20 — — US disclosed
US-20130158025-A1 NOVEL COMPOUND ACTING AS A CANNABINOID RECEPTOR-1 INHIBITOR AMOREPACIFIC CORPORATION (KR) 2013-06-20 — — US disclosed
US-20130158025-A1 NOVEL COMPOUND ACTING AS A CANNABINOID RECEPTOR-1 INHIBITOR AMOREPACIFIC CORPORATION (KR) 2013-06-20 — — US disclosed
WO-2012030170-A2 NOVEL COMPOUND ACTING AS A CANNABINOID RECEPTOR-1 INHIBITOR (주)아모레퍼시픽 (KR) 2012-03-08 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130158025-A1 NOVEL COMPOUND ACTING AS A CANNABINOID RECEPTOR-1 INHIBITOR CNR1, CNR2, GPR18 SPHK2 148/4885SPHK1 88/4885MEN1 3752/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback